FOXA2 and gastric cancer: Moreover, very recent work by Yang et al. demonstrated that histone deacetylase 3 (HDAC3) improved gastric cancer progression by affecting the forkhead box transcription factor A2 (FOXA2)-mediated FTO-m6A-MYC axis [55].